Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Lung Neoplasms 8 Prostatic Neoplasms 6 Neoplasms 6 Colorectal Neoplasms 6 Pancreatic Neoplasms 4 Ovarian Neoplasms 3 Smoking Cessation 2 Skin Carcinoma 2 Pain 2 Melanoma 2 Malignant Solid Neoplasm 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Anatomic Stage I Breast Cancer AJCC v8 2 Advanced Malignant Solid Neoplasm 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Smoking 1 Testicular Neoplasms 1 Spondylitis, Ankylosing 1 Smoking 1 Signs and Symptoms 1 Sepsis 1 Rectal Neoplasms 1

Interventions

Bupivacaine 2 Acetaminophen 2 engage 8200 1 Transdermal Patch 1 Transcutaneous Electric Nerve Stimulation 1 Telemedicine 1 STAMP-I protocol 1 Radiosurgery 1 Palliative Care 1 Oxycodone 1 Methods 1 Ketorolac 1 Ketoprofen 1 Ketamine 1 Capsaicin 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Methods × 90 days × Clear all

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡